Prospection is a technology-driven startup that operates in the pharmaceutical market, providing AI-powered insights to help brands understand patient care journeys. The company's primary offering is its Patient-centric Intelligence Core, a proprietary data and technology engine that analyzes complex, longitudinal patient journeys across hundreds of millions of patients. This engine enables pharmaceutical brands to gain a deep understanding of patient needs and behaviors, thereby reducing the risk of drug launch failures.

Prospection's business model revolves around providing these insights as a service to pharmaceutical brands. These brands use Prospection's data to refine their strategies, optimize their tactical execution, and ultimately improve their market share. The company's AI assistant, ProGPT, also helps brand managers and analysts generate hypotheses and track key performance indicators.

The company's clients are primarily pharmaceutical brands looking to gain a competitive edge by understanding patient behaviors and needs. By providing these brands with a single source of patient-centric intelligence, Prospection helps them unify their understanding of care-and-share across multiple teams, thereby improving their overall brand strategy and performance.

In terms of revenue, Prospection makes money by charging these pharmaceutical brands for access to its data and insights. The company's unique value proposition lies in its ability to provide real-world, transactional data that is both smart and comprehensive, covering everything from regimens and lines of therapy to patient profiles and market share.

Keywords: Pharmaceutical Market, Patient-centric Intelligence, AI-Powered Insights, Drug Launch, Brand Strategy, Data and Technology Engine, ProGPT, Key Performance Indicators, Real-World Data, Market Share.